Government funds Ebola, Marburg vaccine

The federal government has granted researchers at Emory, the Georgia Institute of Technology and Texas Biomed a $5.4 million grant to further develop a vaccine against Ebola and Marburg hemorrhagic. The shot, which uses parts of the virus to elicit immunity, has already been tested in rats and will now be studied in nonhuman primates. Article

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.